Publications by authors named "Bart Claes"

Claim this Profile
E
Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis.
Laure Sorber, Bart Claes, Karen Zwaenepoel, Bieke Van Dorst, Koen De Winne

Am J Clin Pathol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
Joan Maurel, Vicente Alonso, Pilar Escudero, Carlos Fernández-Martos, Antonieta Salud, Bart Claes

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice.
James L Sherwood, Helen Brown, Alessandro Rettino, Amelie Schreieck, Graeme Clark, Bart Claes

ESMO Open· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
Filip Janku, Helen J Huang, Bart Claes, Gerald S Falchook, Siqing Fu

Mol Cancer Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Filip Janku, Bart Claes, Helen J Huang, Gerald S Falchook, Benoit Devogelaere

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis.
Benoit Beuselinck, Alexandra Karadimou, Diether Lambrechts, Bart Claes, Pascal Wolter

Acta Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab.
Christopher G Smith, David Fisher, Bart Claes, Timothy S Maughan, Shelley Idziaszczyk

Clin Cancer Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer.
Sherene Loi, Stefan Michiels, Diether Lambrechts, Debora Fumagalli, Bart Claes

J Natl Cancer Inst· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
Diego A Garcia-Dios, Diether Lambrechts, Lieve Coenegrachts, Ingrid Vandenput, An Capoen, Bart Claes

Gynecol Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive mutation analysis in colorectal flat adenomas.
Quirinus J M Voorham, Beatriz Carvalho, Angela J Spiertz, Bart Claes, Sandra Mongera

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials.
Diether Lambrechts, Bart Claes, Paul Delmar, Joke Reumers, Massimiliano Mazzone

Lancet Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
Annegien Broeks, Marjanka K Schmidt, Mark E Sherman, Fergus J Couch, John L Hopper, Bart Claes

Hum Mol Genet· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
Timothy S Maughan, Richard A Adams, Christopher G Smith, Angela M Meade, Matthew T Seymour, Bart Claes

Lancet· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans

Lancet Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene.
Wim Janssens, Roger Bouillon, Bart Claes, Claudia Carremans, An Lehouck

Thorax· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombomodulin mutations in atypical hemolytic-uremic syndrome.
Mieke Delvaeye, Marina Noris, Astrid De Vriese, Charles T Esmon, Naomi L Esmon, Bart Claes

N Engl J Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer.
Hans Prenen, Jef De Schutter, Bart Jacobs, Wendy De Roock, Bart Biesmans, Bart Claes

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.
Koen Poesen, Diether Lambrechts, Philip Van Damme, Joke Dhondt, Florian Bender, Bart Claes

J Neurosci· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis